Glytec's eGlycemic Management System (eGMS) is a cloud-based, EHR-integrated software solution that supports safe and effective glycemic management and insulin dosing, featuring FDA-cleared Glucommander for personalized insulin dosing decision support.

Glytec eGlycemic Management System (eGMS)

Glytec's eGlycemic Management System (eGMS) is an EHR-integrated, cloud-based software solution that supports safe and effective glycemic management and insulin dosing. This system includes advanced tools for glycemic management analytics, continuous blood glucose surveillance, dynamically adjusted BG check timing, and care coordination dashboards. It integrates with existing EHR platforms such as Epic and Cerner with minimal data entry requirements, enhancing both patient safety and workflow efficiency.

Glucommander Insulin Dosing Support

Glucommander, an FDA-cleared component of Glytec's eGMS, provides personalized insulin dosing decision support for both intravenous (IV) and subcutaneous (SubQ) insulin therapy. It includes safety features such as glucose velocity warnings, anion gap analysis, and the Meter Max™ feature to enhance patient safety. Clinical studies have demonstrated that Glucommander significantly reduces severe hypoglycemia incidents by 99.8% and saves up to 72 minutes per nurse per patient using IV insulin.

GlucoView Dashboard and GlucoSurveillance Analysis

GlucoView, part of Glytec's eGMS, provides a dashboard that displays glycemic status indicators for all patients within a unit, facilitating team nursing and coordination of care. Another module, GlucoSurveillance, performs continuous analysis of blood glucose values to proactively identify patients with hyperglycemia. These tools aid in managing glycemic levels more effectively and reducing the incidence of both hyperglycemia and hypoglycemia.

GlucoMetrics Data Analytics and Reporting

GlucoMetrics, a module within Glytec's eGMS, offers robust glucose data analytics and reporting capabilities. It enables stakeholders to track key performance indicators and optimize patient care strategies. This module supports the overall objective of improving patient safety and outcomes, particularly in complex environments like the ICU. By providing comprehensive data insights, GlucoMetrics assists healthcare providers in making informed decisions to enhance glycemic management.

Proven Benefits and Implementation of Glytec's eGMS

Glytec's eGMS has been validated through clinical studies, showing significant benefits such as reducing the average patient stay by 3.2 days and decreasing 30-day readmissions for AMI, CHF, and CABG patients by 36-68%. The system can be implemented 100% remotely and is EHR agnostic. With support for transitioning patients from IV to subcutaneous therapy and from hospital to home, eGMS is comprehensive in its scope. It also includes a complete training program and 24/7/365 clinical and technical support.

Companies similar to Glytec